Your session is about to expire
← Back to Search
LY3437943 (Control) for Kidney Failure
Study Summary
This trial tests how much medicine reaches the bloodstream in people with kidney issues vs. healthy people, taking up to 5 weeks.
- Kidney Failure
- Healthy Subjects
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 281 Patients • NCT04867785Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are more participants being added to this medical experiment?
"According to clinicaltrials.gov, this medical trial does not require new participants at present. Initially posted on November 4th 2022 and last updated on the 3rd of that month, unfortunately it is inactive for now; however, there are 997 other trials actively recruiting patients as we speak."
Am I eligible to join this clinical experiment?
"This clinical trial is recruiting 20 participants aged between 18 and 85 who are suffering from kidney failure. To be eligible for enrolment, potential candidates must meet the following criteria: healthy male/female as evidenced by physical examination; normal renal function reflected in an eGFR of 90mL/min or higher; BMI ranging from 19.0-40.0kg/m2; males using contraception and females of childbearing age adhering to contraceptive methods (women not of childbearing age can still participate); acceptable BP and pulse rate according to investigator's judgement; Type 2 diabetic patients with HbA1c levels between 5.0"
Has the FDA sanctioned LY3437943 (Severe Renal Impairment) for public consumption?
"Based on the current available information, LY3437943 (Severe Renal Impairment) is deemed to be safe enough for a Phase 1 trial and therefore receives a score of 1."
Is this trial open to participants of all ages, including minors?
"This clinical trial requires that participants are between 18 and 85 years of age. For individuals younger than the former or older than the latter, there are 56 trials specifically for minors and 524 study opportunities available to senior citizens respectively."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger